Skip to main content
. 2024 Mar 5;32(5):479–488. doi: 10.1038/s41431-023-01507-5

49. If the reclassification of a variant alters the clinical significance (i.e. from VUS to LP/LP to VUS), laboratories must assess if a reissue of a report to the referring consultant of the proband is required [55].

50. Any reissued report must clearly state that it is an updated report which supersedes the previously issued report.